|
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
|
|
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:
|
ARK THERAPEUTICS GROUP PLC
|
|
2 Reason for the notification (please tick the appropriate box or boxes):
|
|
An acquisition or disposal of voting rights
|
x
|
|
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
|
|
|
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
|
|
|
An event changing the breakdown of voting rights
|
|
|
Other (please specify):
|
|
|
|
3. Full name of person(s) subject to the notification obligation:
|
Smith & Williamson Holdings Limited
|
|
4. Full name of shareholder(s) (if different from 3.):
|
See section 9
|
|
5. Date of the transaction and date on which the threshold is crossed or reached:
|
22.07.10
|
|
6. Date on which issuer notified:
|
27.07.10
|
|
7. Threshold(s) that is/are crossed or reached:
|
5%
|
|
8. Notified details:
|
|
A: Voting rights attached to shares
|
|
Class/type of
shares
if possible using
the ISIN CODE
|
Situation previous
to the triggering
transaction
|
Resulting situation after the triggering transaction
|
|
Number
of
Shares
|
Number
of
Voting
Rights
|
Number
of shares
|
Number of voting
rights
|
% of voting rights
|
|
Direct
|
Direct
|
Indirect
|
Direct
|
Indirect
|
|
Ordinary
GB0034251727
|
10,029,600
|
10,029,600
|
|
|
11,029,600
|
|
5.28%
|
|
|
|
B: Financial Instruments
|
|
Resulting situation after the triggering transaction
|
|
Type of financial
instrument
|
Exercise
price
|
Expiration
date
|
Exercise/
Conversion
period
|
Number of voting
rights instrument
refers to
|
% of voting rights
|
|
N/A
|
|
|
|
|
Nominal
|
Delta
|
|
|
|
|
Total (A+B)
|
|
Number of voting rights
|
Percentage of voting rights
|
|
11,029,600
|
5.28%
|
|
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
|
|
Smith and Williamson Nominees Limited, a subsidiary of Smith and Williamson Investment Management Limited, a subsidiary of Smith and Williamson Holdings Limited - 3,759,600 shares
Bank of New York Nominees as custodian for Smith & Williamson Investment Management Limited, a subsidiary of Smith & Williamson Holdings Limited - 1,150,000 shares
BNP Paribas as custodian for Smith and Williamson Investment Management Limited, a subsidiary of Smith and Williamson Holdings Limited - 320,000 shares
BNP Paribas Securities Services as custodian for Smith & Williamson Investment Management (Ireland) Limited, a subsidiary of Smith & Williamson Holdings Limited - 5,625,000
|
|
Proxy Voting:
|
|
10. Name of the proxy holder:
|
N/A
|
|
11. Number of voting rights proxy holder will cease to hold:
|
N/A
|
|
12. Date on which proxy holder will cease to hold voting rights:
|
N/A
|
|
13. Additional information:
|
|
|
14. Contact name:
|
Stephen Hamilton-Jones, Smith & Williamson Investment Management Limited
|
|
15. Contact telephone number:
|
020 7131 4734
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|